Rheumatology Associates of North Alabama, PC

Huntsville, Alabama 35801-4418

0 studies enrolling now · 26 studies all time

What they study most

Ankylosing Spondylitis, Arthritis, Arthritis, Psoriatic, Arthritis, Rheumatoid, Chronic Pain, Crohn's Disease, Enteropathic Arthritis, Fibromyalgia, Inflammatory Arthritis, Lupus, Osteoarthritis, Osteoarthritis, Hip

Studies at this site

• Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis — Completed
• Phase 2 Study of TD-9855 to Treat Fibromyalgia — Completed
• Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial) — Completed
• Efficacy and Safety of Tofacitinib in Subjects With Active Ankylosing Spondylitis (AS) — Completed
• Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis — Completed
• Effects of Abatacept in Patients With Early Rheumatoid Arthritis — Completed
• Long-Term Analgesic Efficacy And Safety Of Tanezumab Alone Or In Combination With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Versus NSAIDs Alone In Patients With Osteoarthritis Of The Knee Or Hip — Stopped early
• Phase IIB Dose Ranging Study in Subjects With Moderate to Severe Rheumatoid Arthritis — Completed
• Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen — Completed
• Dose-finding Study of GLPG0634 as add-on to Methotrexate in Active Rheumatoid Arthritis Participants (DARWIN1) — Completed
• Study to Assess Changes in the Immune Profile in Adults With Early Rheumatoid Arthritis — Completed
• Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis — Completed
• Long Term Safety and Efficacy Study of Tanezumab in Subjects With Osteoarthritis of the Hip or Knee — Completed
• Methotrexate Withdrawal Study of Tofacitinib Modified Release Formulation in Subjects With Rheumatoid Arthritis — Completed
• A Pharmacokinetic/Pharmacodynamic Study Comparing PF-05280586 To Rituximab In Subjects With Active Rheumatoid Arthritis With An Inadequate Response To TNF Inhibitors (REFLECTIONS B328-01) — Completed
• Safety and Efficacy Study of a Biologic to Treat Systemic Lupus Erythematosus — Completed
• Efficacy and Safety Study of BMS-986142 in Patients With Moderate to Severe Rheumatoid Arthritis — Completed
• Rheumatoid Arthritis Extension Trial For Subjects Who Have Participated In Other PF-05280586 Trials (REFLECTIONS B328-04) — Completed
• Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis — Completed
• Prospective Outcomes Study: Vectra® DA Guided Care Compared to Usual Care — Status unconfirmed
• An Efficacy And Safety Study Evaluating Tofacitinib With And Without Methotrexate Compared To Adalimumab With Methotrexate — Completed
• GP2013 Treatment in Patients With Active Rheumatoid Arthritis, Previously Treated With Rituxan® or MabThera® — Completed
• Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors — Completed
• Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study — Completed
• Efficacy and Safety Study of Abatacept Subcutaneous Plus Methotrexate in Inducing Remission in Adults With Very Early Rheumatoid Arthritis — Completed
• Study to Characterize the Pharmacokinetics of a Single Dose of SC Abatacept 125 mg Using the BD Autoinjector or the Prefilled Syringe — Completed